Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum levels of soluble syndecan-1 in Hodgkin's lymphoma.
Vassilakopoulos TP, Kyrtsonis MC, Papadogiannis A, Nadali G, Angelopoulou MK, Tzenou T, Dimopoulou MN, Siakantaris MP, Kontopidou FN, Kalpadakis C, Kokoris SI, Dimitriadou EM, Tsaftaridis P, Pizzolo G, Pangalis GA. Vassilakopoulos TP, et al. Among authors: tsaftaridis p. Anticancer Res. 2005 Nov-Dec;25(6C):4743-6. Anticancer Res. 2005. PMID: 16334170 Free article.
Hodgkin's lymphoma in first relapse following chemotherapy or combined modality therapy: analysis of outcome and prognostic factors after conventional salvage therapy.
Vassilakopoulos TP, Angelopoulou MK, Siakantaris MP, Kontopidou FN, Dimopoulou MN, Boutsis DE, Anargyrou K, Kokoris SI, Giannakakis A, Karkantaris C, Kyrtsonis MC, Tsaftaridis P, Rombos J, Variamis E, Korkolopoulou P, Kittas C, Pangalis GA. Vassilakopoulos TP, et al. Among authors: tsaftaridis p. Eur J Haematol. 2002 May;68(5):289-98. doi: 10.1034/j.1600-0609.2002.01721.x. Eur J Haematol. 2002. PMID: 12144535
Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
Vassilakopoulos TP, Angelopoulou MK, Siakantaris MP, Kontopidou FN, Dimopoulou MN, Kokoris SI, Kyrtsonis MC, Tsaftaridis P, Karkantaris C, Anargyrou K, Boutsis DE, Variamis E, Michalopoulos T, Boussiotis VA, Panayiotidis P, Papavassiliou C, Pangalis GA. Vassilakopoulos TP, et al. Among authors: tsaftaridis p. Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):765-81. doi: 10.1016/j.ijrobp.2003.11.029. Int J Radiat Oncol Biol Phys. 2004. PMID: 15183480
Treatment of splenic marginal zone lymphoma with rituximab monotherapy: progress report and comparison with splenectomy.
Kalpadakis C, Pangalis GA, Angelopoulou MK, Sachanas S, Kontopidou FN, Yiakoumis X, Kokoris SI, Dimitriadou EM, Dimopoulou MN, Moschogiannis M, Korkolopoulou P, Kyrtsonis MC, Siakantaris MP, Papadaki T, Tsaftaridis P, Plata E, Papadaki HE, Vassilakopoulos TP. Kalpadakis C, et al. Among authors: tsaftaridis p. Oncologist. 2013;18(2):190-7. doi: 10.1634/theoncologist.2012-0251. Epub 2013 Jan 23. Oncologist. 2013. PMID: 23345547 Free PMC article.
Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens.
Vassilakopoulos TP, Dimopoulou MN, Angelopoulou MK, Petevi K, Pangalis GA, Moschogiannis M, Dimou M, Boutsikas G, Kanellopoulos A, Gainaru G, Plata E, Flevari P, Koutsi K, Papageorgiou L, Telonis V, Tsaftaridis P, Sachanas S, Yiakoumis X, Tsirkinidis P, Viniou NA, Siakantaris MP, Variami E, Kyrtsonis MC, Meletis J, Panayiotidis P, Konstantopoulos K. Vassilakopoulos TP, et al. Among authors: tsaftaridis p. Oncologist. 2016 Mar;21(3):343-53. doi: 10.1634/theoncologist.2015-0251. Epub 2016 Feb 26. Oncologist. 2016. PMID: 26921291 Free PMC article.
Recurrent acute myopericarditis without effusion during ATRA induction and ATO salvage of APL: a variant form of the differentiation syndrome?
Vassilakopoulos TP, Asimakopoulos JV, Plata E, Kelepesis G, Petevi K, Koutsi C, Papageorgiou L, Tsaftaridis P, Angelopoulou MK, Konstantopoulos K, Meletis J. Vassilakopoulos TP, et al. Among authors: tsaftaridis p. Leuk Lymphoma. 2017 Jul;58(7):1743-1746. doi: 10.1080/10428194.2016.1253838. Epub 2016 Dec 6. Leuk Lymphoma. 2017. PMID: 27919176 No abstract available.
Study of bone metabolism and angiogenesis in patients undergoing high-dose chemotherapy/autologous hematopoietic stem cell transplantation.
Boutsikas G, Terpos E, Papatheodorou A, Tsirkinidis P, Tsirigotis P, Meletiou A, Lalou E, Telonis V, Zannou A, Kanellopoulos A, Galani Z, Stefanou A, Tsaftaridis P, Viniou NA, Panayiotidis P, Kyrtsonis MC, Meletis J, Vassilakopoulos TP, Angelopoulou MK. Boutsikas G, et al. Among authors: tsaftaridis p. Eur J Haematol. 2018 Feb;100(2):131-139. doi: 10.1111/ejh.12990. Epub 2017 Dec 4. Eur J Haematol. 2018. PMID: 29105864
Safety and efficacy analysis of long-term follow up real-world data with ibrutinib monotherapy in 58 patients with CLL treated in a single-center in Greece.
Dimou M, Iliakis T, Pardalis V, Bitsani C, Vassilakopoulos TP, Angelopoulou M, Tsaftaridis P, Papaioannou P, Koudouna A, Kalyva S, Kyrtsonis MC, Panayiotidis P. Dimou M, et al. Among authors: tsaftaridis p. Leuk Lymphoma. 2019 Dec;60(12):2939-2945. doi: 10.1080/10428194.2019.1620944. Epub 2019 Jun 11. Leuk Lymphoma. 2019. PMID: 31184241
32 results